Ticker
ORMPCompany Name
ORAMED PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -16.07M | -803.3% | $ 2M |
3/31/2025 | $ -10.46M | -522.75% | $ 2M |
12/31/2024 | $ -8.41M | 0% | $ 0 |
9/30/2024 | $ -7.92M | 0% | $ 0 |
6/30/2024 | $ -1.51M | 0% | $ 0 |
3/31/2024 | $ -6.22M | -923.15% | $ 674K |
12/31/2023 | $ -10.29M | -768.28% | $ 1.34M |
9/30/2023 | $ -16.94M | -838.15% | $ 2.02M |
6/30/2023 | $ -18.49M | -683.91% | $ 2.7M |
3/31/2023 | $ -24.34M | -900.55% | $ 2.7M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for ORAMED PHARMACEUTICALS INC is calculated as follows: CF - Operations [ $ -12.44M ] / Revenues [ $ 2.71M ]
(=) OCF % [ -459.04% ]
Minimum
Sep 30, 2022
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 78.12% |
average | 14.35% |
median | 12.67% |
std | 21.14% |